Graduated in Physiology from the University of Sheffield (1986) with a PhD in Neurophysiology and Neuropharmacology from the University of Nottingham (1990). He directs basic and clinical studies of the pathophysiological mechanisms of chronic sensorimotor complications of spinal cord injury focussed on spasticity and neuropathic pain both in Toledo and in Aylesbury. He is member of the Society for Neuroscience (1990), IASP (2001) and founding member of the Castilla LaMancha Pain Society (2010). He is also responsible for clinical initiatives related to chronic SCI complications for the National Spinal Cord Injury Hospitals in the UK and Spain. In the clinical labs several techniques are being developed to improve early diagnosis of adaptive or maladaptive mechanisms related to neuropathic pain and spasticity in subjects with SCI, using neurophysiological, functional and pyschophysical techniques. In the animal lab in Toledo he is evaluating a humanised pharmacological strategy based on a modified omega-9 fatty acid for the treatment of SCI chronic complications, in addition to developing experimental techniques designed to facilitate treatment response of those high-impact symptoms identified from patients.